Cargando…

Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics are the most commonly used drugs and are increasingly available over-the-counter (OTC). In certain groups of patients, including kidney transplant recipients, their use may be complicated by adverse effects or drug interactions...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulka-Gierek, Maria, Foroncewicz, Bartosz, Pączek, Leszek, Wawiórko, Elżbieta, Kamińska, Joanna, Kosieradzki, Maciej, Małkowski, Piotr, Małczuk, Bianka, Nazarewski, Sławomir, Mucha, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248020/
https://www.ncbi.nlm.nih.gov/pubmed/29497028
http://dx.doi.org/10.12659/AOT.905856
_version_ 1783372580689805312
author Mulka-Gierek, Maria
Foroncewicz, Bartosz
Pączek, Leszek
Wawiórko, Elżbieta
Kamińska, Joanna
Kosieradzki, Maciej
Małkowski, Piotr
Małczuk, Bianka
Nazarewski, Sławomir
Mucha, Krzysztof
author_facet Mulka-Gierek, Maria
Foroncewicz, Bartosz
Pączek, Leszek
Wawiórko, Elżbieta
Kamińska, Joanna
Kosieradzki, Maciej
Małkowski, Piotr
Małczuk, Bianka
Nazarewski, Sławomir
Mucha, Krzysztof
author_sort Mulka-Gierek, Maria
collection PubMed
description BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics are the most commonly used drugs and are increasingly available over-the-counter (OTC). In certain groups of patients, including kidney transplant recipients, their use may be complicated by adverse effects or drug interactions. The aim of our study was to assess the causes and frequency of OTC NSAIDs or analgesics use, as well as the awareness of related side effects. MATERIAL/METHODS: We enrolled 94 randomly selected kidney transplant recipients, who represented 5% of all kidney transplant recipients at our center. An anonymous survey consisting of 23 multiple-choice questions was administered voluntarily and anonymously. RESULTS: In all, 63% of study patients confirmed taking the OTC painkillers; 22% of these patients took these drugs at least several times a week, and 4% took these drugs daily. For 38% of the study kidney transplant recipients, NSAIDs or analgesics were reported to be the only way to manage their pain. In addition, 30% of study patients were unaware of the risks associated with these drugs, despite the fact that 89% of the study patients consider physicians the best source of information. CONCLUSIONS: Our study found that 63% of kidney transplant recipients regularly took OTC painkillers and 30% were unaware of the potential adverse effects. This necessitates continuous, ongoing education of kidney transplant recipients about the risks of OTC NSAIDs or analgesics use.
format Online
Article
Text
id pubmed-6248020
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-62480202018-11-28 Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients Mulka-Gierek, Maria Foroncewicz, Bartosz Pączek, Leszek Wawiórko, Elżbieta Kamińska, Joanna Kosieradzki, Maciej Małkowski, Piotr Małczuk, Bianka Nazarewski, Sławomir Mucha, Krzysztof Ann Transplant Original Paper BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics are the most commonly used drugs and are increasingly available over-the-counter (OTC). In certain groups of patients, including kidney transplant recipients, their use may be complicated by adverse effects or drug interactions. The aim of our study was to assess the causes and frequency of OTC NSAIDs or analgesics use, as well as the awareness of related side effects. MATERIAL/METHODS: We enrolled 94 randomly selected kidney transplant recipients, who represented 5% of all kidney transplant recipients at our center. An anonymous survey consisting of 23 multiple-choice questions was administered voluntarily and anonymously. RESULTS: In all, 63% of study patients confirmed taking the OTC painkillers; 22% of these patients took these drugs at least several times a week, and 4% took these drugs daily. For 38% of the study kidney transplant recipients, NSAIDs or analgesics were reported to be the only way to manage their pain. In addition, 30% of study patients were unaware of the risks associated with these drugs, despite the fact that 89% of the study patients consider physicians the best source of information. CONCLUSIONS: Our study found that 63% of kidney transplant recipients regularly took OTC painkillers and 30% were unaware of the potential adverse effects. This necessitates continuous, ongoing education of kidney transplant recipients about the risks of OTC NSAIDs or analgesics use. International Scientific Literature, Inc. 2018-03-02 /pmc/articles/PMC6248020/ /pubmed/29497028 http://dx.doi.org/10.12659/AOT.905856 Text en © Ann Transplant, 2018 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Original Paper
Mulka-Gierek, Maria
Foroncewicz, Bartosz
Pączek, Leszek
Wawiórko, Elżbieta
Kamińska, Joanna
Kosieradzki, Maciej
Małkowski, Piotr
Małczuk, Bianka
Nazarewski, Sławomir
Mucha, Krzysztof
Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title_full Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title_fullStr Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title_full_unstemmed Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title_short Nonsteroidal Anti-Inflammatory Drugs and Analgesics Use by Kidney Transplant Recipients
title_sort nonsteroidal anti-inflammatory drugs and analgesics use by kidney transplant recipients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248020/
https://www.ncbi.nlm.nih.gov/pubmed/29497028
http://dx.doi.org/10.12659/AOT.905856
work_keys_str_mv AT mulkagierekmaria nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT foroncewiczbartosz nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT paczekleszek nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT wawiorkoelzbieta nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT kaminskajoanna nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT kosieradzkimaciej nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT małkowskipiotr nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT małczukbianka nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT nazarewskisławomir nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients
AT muchakrzysztof nonsteroidalantiinflammatorydrugsandanalgesicsusebykidneytransplantrecipients